Uttar Pradesh and Japan explore deeper collaboration in pharmaceutical manufacturing

An online meeting was held at the Invest UP office on Friday with the Kansai Pharmaceutical Industries Association, Japan, to promote collaboration in pharmaceutical manufacturing and research in Uttar Pradesh.

The session focused on identifying partnership opportunities between leading pharmaceutical companies from Uttar Pradesh and Japan.

Advertisement

The meeting was chaired by Awanish Awasthi, Advisor to the Chief Minister, along with senior officials from Invest UP.

More than 125 leading Japanese pharmaceutical companies participated virtually, along with representatives from Indian firms such as TI Medicals, Torrent Pharma, and 3xper Innoventure. From Japan, Dr. Yoshikazu Hayashi, Director General of the Kansai Pharmaceutical Industries Association, and Prof. Atsuko Kamiike from Chuo Gakuin University represented the delegation.

Discussions centered on the current landscape and future potential of India’s pharmaceutical industry, with a special focus on Uttar Pradesh’s emergence as a hub for pharmaceutical manufacturing, innovation, and R&D. Prof. Kamiike praised India’s pharmaceutical sector for its innovation, reliability, and global competitiveness, describing India as the “Pharmacy of the World.”

Highlighting Uttar Pradesh’s strengths, Awanish Awasthi said that the state has the potential to emerge as a leading pharmaceutical hub. He noted that this is supported by premier institutions such as KGMU, SGPGI, two AIIMS, over 200 medical colleges, and more than 25 MedTech startups, which are collectively producing a skilled workforce for Contract Development and Manufacturing Organizations (CDMOs).

He also underscored Uttar Pradesh’s world-class infrastructure, which includes 13 expressways (7 operational and 6 upcoming), 5 international airports, and 16 domestic airports. He emphasized the state’s strategic proximity to the National Capital Region (NCR), its vast consumer base, and significant demographic dividend—with 56% of the population in the working-age group.

Additionally, he highlighted the Uttar Pradesh Investment Promotion Policy 2023 for FDI/FCI, Fortune Global 500, and Fortune India 500 companies, which offers attractive incentives and subsidies to investors, along with 33 investor-friendly sectoral policies.

Invest UP invited the Japanese delegation to explore investment prospects in the state and experience Uttar Pradesh’s rich cultural heritage, marking an important step toward advancing India–Japan collaboration in the global pharmaceutical value chain.